# Jade Biosciences

Jade Biosciences is an Asset Manager based in Philadelphia, United States.

## Overview

- **Organization type:** Asset Manager
- **Headquarters:** Philadelphia, United States
- **Region:** North America
- **Address:** Philadelphia, United States
- **Assets under management:** Undisclosed
- **Website:** jadebiosciences.com
- **LinkedIn:** https://www.linkedin.com/company/jade-biosciences

## Regulatory record

- **Reports private funds:** No

## About

Jade Biosciences develops therapies for autoimmune diseases within the biotechnology sector. The company creates treatments for patients with these conditions. Founded in 2024, Jade Biosciences is based in Philadelphia, Pennsylvania.

## Sectors

- Digital Health
- Healthcare Services

## People

- Tom Frohlich — Chief Executive Officer
- Andrew King — President, Research & Development
- Edward R. Conner — Chief Medical Officer
- Brad Dahms — Chief Financial Officer
- Eric Dobmeier — Board Chair and Venture Partner, Samsara Biocapital
- Chris Cain — Director of Research, Fairmount
- Tomas Kiselak — Founding Partner, Fairmount
- Lawrence Klein — Chief Executive Officer, Oruka Therapeutics
- Erin Lavelle — Former COO and CFO, ProfoundBio and Eliem Therapeutics

## Questions

### How does Jade Biosciences source its drug candidates?

Jade does not maintain an internal research lab. The company exclusively in-licenses discovery-stage assets from Paragon Therapeutics, an antibody discovery engine founded by Fairmount. This creates a pipeline without the capital outlay typical of early-stage biologics research.

### What is Jade's sole publicly disclosed drug program?

JADE101 is the only named asset. The drug is designed to inhibit the cytokine APRIL and is being developed for immunoglobulin A nephropathy (IgAN). The company does not specify a timeline for clinical data or additional indications in its public materials.

## Related profiles

- [Distributed Ventures](https://altss.com/profile/distributed-global)
- [Hipcamp](https://altss.com/profile/hipcamp)

---

Last updated: 2026-06-03T20:00:00.000Z

Canonical page: https://altss.com/profile/jade-biosciences

Maintained by Altss — https://altss.com — methodology: https://altss.com/methodology